Allison Braly

Allison Braly currently serves as the Vice President of Clinical Strategy and Operations at Beacon Biosignals since 2025. Prior to this role, Braly held positions as the Vice President of Clinical Operations at Lark Health from 2023 to 2025, leading efforts in AI digital health technology for chronic condition management, and as the Vice President of Diagnostic Strategy at PathAI from 2021 to 2023, focusing on AI-powered pathology tools. Braly's earlier experience includes positions at Amwell, where responsibilities encompassed leadership of Clinical Services and Clinical Operations, contributing significantly to revenue generation and operational efficiency. Other past roles include Administrative Director of the Kraft Precision Medicine Accelerator at Harvard Business School and various positions in business development and clinical strategy in healthcare organizations. Braly holds an MBA with a concentration in Strategy from Duke University and a Bachelor of Science in Biomedical Engineering from Marquette University.